Recent studies have shown that CD24 is overexpressed in various human tumors, including liver cancer, thyroid cancer, and esophageal cancer, where it plays a crucial role in tumor initiation, progression, invasion, and metastasis. This evidence concerns the gene CD24 and liver cancer.